RecallDepth
Class III Terminated

Loteprednol Etabonate Ophthalmic Suspension, 5 mg/mL (0.5%), packaged as one bottle in a carton in a) 10 mL bottle (NDC# 62756-232-55) and b) 15 mL bottle (NDC # 62756-232-56), Rx only, Distributed by: Sun Pharmaceutical Ind., Inc., NJ 08512, Manufactured by: Sun Pharmaceutical Medicare Ltd., India.

Company
Sun Pharmaceutical Industries Inc
Recall Initiated
July 5, 2023
Posted
July 26, 2023
Recall Number
D-0924-2023
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
20,884 cartons
Firm Location
Princeton, NJ, United States

Reason for Recall

Superpotent Drug: Out of Specification (OOS) results observed for unit dose content.

Distribution

USA nationwide.

Lot / Code Info

Lot#: a) BAC0334A, Exp 06/2023; BAC0532A, Exp 11/2023 BAD0407A, Exp 08/2024 BAD0425A, Exp 08/2024; b) BAC0335A, Exp 06/2023, BAC0533A, Exp 10/2023, BAD0148A, Exp 03/2024, BAD0320A, Exp 07/2024

More recalls by Sun Pharmaceutical Industries Inc

View all recalls by this company →

Other recent Class III Drug recalls